DOCU

SEC source: 0001261333-20-000227 · wf-form4_160220037932779.xml · nonDerivative · entry 3

OLRICH SCOTT V. · CIK 0001517211 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,954

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F4 · price: The shares were sold at prices ranging from $224.24 to $225.21. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000227 · wf-form4_160220037932779.xml · nonDerivative · entry 2

OLRICH SCOTT V. · CIK 0001517211 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,511

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F3 · price: The shares were sold at prices ranging from $223.24 to $224.23. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000227 · wf-form4_160220037932779.xml · nonDerivative · entry 1

OLRICH SCOTT V. · CIK 0001517211 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,054

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F2 · price: The shares were sold at prices ranging from $222.18 to $223.04. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000899243-20-026664 · doc4.xml · nonDerivative · entry 2

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,093

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.41 to $216.21, inclusive.

SEC source: 0000899243-20-026664 · doc4.xml · nonDerivative · entry 1

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,593

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $212.61 to $213.33, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

SEC source: 0001261333-20-000272 · wf-form4_160816163857584.xml · nonDerivative · entry 3

Springer Daniel D. · CIK 0001517205 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,663,434

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 22

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 77,624

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F23 · price: The shares were sold at prices ranging from $204.87 to $205.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 21

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 77,995

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F22 · price: The shares were sold at prices ranging from $203.55 to $204.44. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 20

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 78,502

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F21 · price: The shares were sold at prices ranging from $202.22 to $203.05. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 19

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 79,502

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F20 · price: The shares were sold at prices ranging from $201.09 to $202.05. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 18

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 80,402

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F19 · price: The shares were sold at prices ranging from $198.85 to $199.63. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 17

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 80,990

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F18 · price: The shares were sold at prices ranging from $197.26 to $197.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 16

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 81,590

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F17 · price: The shares were sold at prices ranging from $195.06 to $195.15. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 15

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 81,790

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

F16 · price: The shares were sold at prices ranging from $193.83 to $193.84. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 14

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Children's Trusts

Disclosed balance after: 81,990

F15 · kind: The transaction was effected pursuant to Rule 10b5-1 plans adopted by each of the Children's Trusts, respectively.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 13

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 190,889

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F14 · price: The shares were sold at prices ranging from $204.73 to $205.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 12

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 192,022

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F13 · price: The shares were sold at prices ranging from $203.72 to $204.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 11

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 193,222

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F12 · price: The shares were sold at prices ranging from $202.66 to $203.47. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 10

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 194,645

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F11 · price: The shares were sold at prices ranging from $201.65 to $202.64. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 9

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 197,189

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F10 · price: The shares were sold at prices ranging from $200.58 to $201.54. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 8

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 198,550

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F9 · price: The shares were sold at prices ranging from $199.52 to $200.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 7

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 199,055

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F8 · price: The shares were sold at prices ranging from $198.41 to $199.13. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 6

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 199,915

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F7 · price: The shares were sold at prices ranging from $197.26 to $198.13. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 5

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 201,015

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F6 · price: The shares were sold at prices ranging from $196.24 to 196.59. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 4

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 201,315

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F5 · price: The shares were sold at prices ranging from $195.05 to $196.02. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 3

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 202,175

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F4 · price: The shares were sold at prices ranging from $193.73 to $193.79. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 2

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 202,375

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F3 · price: The shares were sold at prices ranging from $192.18 to $193.15. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000223 · wf-form4_160081041702586.xml · nonDerivative · entry 1

Solvik Peter · CIK 0001686308 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 202,575

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person's trust.

F2 · price: The shares were sold at prices ranging from $191.03 to $191.05. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0000899243-20-025917 · doc4.xml · nonDerivative · entry 7

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,325,000

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.50 to $195.25, inclusive.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-20-025917 · doc4.xml · nonDerivative · entry 6

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,336,715

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.31 to $194.06, inclusive.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-20-025917 · doc4.xml · nonDerivative · entry 5

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,338,415

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.28 to $193.15, inclusive.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-20-025917 · doc4.xml · nonDerivative · entry 4

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,343,312

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.27 to $192.25, inclusive.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-20-025917 · doc4.xml · nonDerivative · entry 3

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,350,612

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.25 to $191.24, inclusive.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-20-025917 · doc4.xml · nonDerivative · entry 2

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,358,875

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.24 to $190.22, inclusive.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-20-025917 · doc4.xml · nonDerivative · entry 1

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,368,491

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.22 to $189.18, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (9) to this Form 4.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0001261333-20-000221 · wf-form4_160046927087098.xml · derivative · entry 2

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,483

Underlying: Common Stock · 1,742 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs will vest in twelve equal quarterly installments over three years, with a vesting commencement date of March 17, 2018, in each case subject to the Reporting Person serving as a Director of the Board of the Issuer through each such date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date.

SEC source: 0001261333-20-000221 · wf-form4_160046927087098.xml · nonDerivative · entry 1

Wilderotter Mary Agnes · CIK 0001180610 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,563

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261333-20-000220 · wf-form4_160046925374437.xml · derivative · entry 5

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,000

Underlying: Common Stock · 8,000 shares

Expires 2023-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This stock option was fully vested on the transaction date.

SEC source: 0001261333-20-000220 · wf-form4_160046925374437.xml · nonDerivative · entry 4

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,973

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001261333-20-000220 · wf-form4_160046925374437.xml · nonDerivative · entry 3

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,973

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F4 · price: The shares were sold at prices ranging from $193.13 to $194.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000220 · wf-form4_160046925374437.xml · nonDerivative · entry 2

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,044

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F3 · price: The shares were sold at prices ranging from $192.06 to $193.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000220 · wf-form4_160046925374437.xml · nonDerivative · entry 1

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,920

F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

F2 · price: The shares were sold at prices ranging from $191.06 to $191.97. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001261333-20-000216 · wf-form4_160038588328523.xml · derivative · entry 4

Phi Tram T · CIK 0001424551 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,014

Underlying: Common Stock · 734 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F6 · derivative.exercise_date: The RSUs will vest in sixteen equal quarterly installments over four years, with a vesting commencement date of June 10, 2020, in each case subject to the Reporting Person being a service provider through each such date.The RSUs are subject to accelerated vesting in the event of a termination of employment of the Reporting Person including under certain circumstances following a change in control of the Issuer.

F5 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date.

SEC source: 0001261333-20-000216 · wf-form4_160038588328523.xml · derivative · entry 3

Phi Tram T · CIK 0001424551 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,196

Underlying: Common Stock · 14,732 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F4 · derivative.exercise_date: Twenty-five percent of the total RSUs granted vested on July 10, 2020, and the balance of the RSUs shall vest in twelve equal quarterly installments until fully vested on July 20, 2023, in each case subject to the Reporting Person being a service provider through each such date. The RSUs are subject to accelerated vesting in the event of a termination of employment of the Reporting Person including under certain circumstances following a change in control of the Issuer.

F5 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date.

SEC source: 0001261333-20-000216 · wf-form4_160038588328523.xml · nonDerivative · entry 2

Phi Tram T · CIK 0001424551 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,968

F2 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting and settlement of restricted stock units.

SEC source: 0001261333-20-000216 · wf-form4_160038588328523.xml · nonDerivative · entry 1

Phi Tram T · CIK 0001424551 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Securities Beneficially Owned includes shares acquired pursuant to issuer's employee stock purchase plan in a transaction exempt under Rule 16b-3.

SEC source: 0000899243-20-025529 · doc4.xml · nonDerivative · entry 1

Salem Enrique T · CIK 0001295402 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,374,299

F3 · kind: On September 15, 2020, certain of the Bain Venture Entities distributed an aggregate of 613,201 shares of Common Stock to one or more partners in pro-rata in-kind distributions without consideration, including an aggregate of 12,746 shares of Common Stock that were distributed to Mr. Salem.

F1 · ownership.nature: Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

SEC source: 0001261333-20-000217 · wf-form4_160038590284506.xml · derivative · entry 7

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,897

Underlying: Common Stock · 1,193 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F8 · derivative.exercise_date: The RSUs will vest in sixteen equal quarterly installments over four years, with a vesting commencement date of June 10, 2020, in each case subject to the Reporting Person being a service provider through such date.The restricted stock units are subject to accelerated vesting in the event of a termination of employment of the Reporting Person including under certain circumstances following a change in control of the Issuer.

F4 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date.

SEC source: 0001261333-20-000217 · wf-form4_160038590284506.xml · derivative · entry 6

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 2,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F7 · derivative.exercise_date: The RSUs will vest in sixteen equal quarterly installments over four years, with a vesting commencement date of May 10, 2017, in each case subject to the Reporting Person being a service provider through each such date. The RSUs are subject to accelerated vesting in the event of a termination of employment of the Reporting Person including under certain circumstances following a change in control of the Issuer.

F4 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date.

SEC source: 0001261333-20-000217 · wf-form4_160038590284506.xml · derivative · entry 5

Alhadeff Loren · CIK 0001765953 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer upon vesting.

F6 · derivative.exercise_date: The RSUs will vest in sixteen equal quarterly installments over four years, with a vesting commencement date of September 10, 2016, in each case subject to the Reporting Person being a service provider through each such date. The RSUs are subject to accelerated vesting in the event of a termination of employment of the Reporting Person including under certain circumstances following a change in control of the Issuer.

F4 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vesting date.